Can a Polyphenol-Rich Intervention Help Prevent Type 2 Diabetes?

Prediabetes represents a critical window during which nutritional interventions may help restore metabolic balance before type 2 diabetes becomes established.

A randomized, double-blind, placebo-controlled clinical trial investigated TOTUM-63, a standardized plant-based combination rich in polyphenols, in participants with prediabetes or recently diagnosed type 2 diabetes who were not receiving glucose-lowering medication.

After six months, participants receiving TOTUM-63 showed improvements in fasting blood glucose and glucose tolerance compared with placebo. The intervention was also associated with favourable changes in body weight, waist circumference, blood lipids and blood pressure.

The study is important because it moves polyphenol research beyond isolated compounds and laboratory models. It evaluates a standardized combination of plant bioactives in a clinically relevant population and addresses a major question:

Can polyphenol-rich interventions complement lifestyle strategies during the early stages of metabolic disease?

The findings suggest that carefully characterized polyphenol combinations could contribute to future nutritional approaches for improving glucose regulation. However, larger and longer clinical trials are still required to determine whether these metabolic improvements can meaningfully delay or prevent progression to type 2 diabetes.

This research also highlights a central theme of Polyphenols Applications 2026: translating the biological complexity of polyphenols into standardized, measurable and clinically relevant applications.

These questions will be discussed during the 19th World Congress on Polyphenols Applications, taking place on October 8–9, 2026, in Málaga, Spain.

For more information:

Read the full news here

Read the news on LinkedIn